Ondine Biomedical Inc (OBI)

Currency in GBP
14.50
+1.00(+7.41%)
Closed·
OBI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
OBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.5014.85
52 wk Range
5.5015.00
Key Statistics
Bid/Ask
13.50 / 15.00
Prev. Close
13.5
Open
14
Day's Range
14.5-14.85
52 wk Range
5.5-15
Volume
367.2K
Average Volume (3m)
285.92K
1-Year Change
71.43%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Ondine Biomedical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Ondine Biomedical Inc Company Profile

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Compare OBI to Peers and Sector

Metrics to compare
OBI
Peers
Sector
Relationship
P/E Ratio
−5.8x−5.6x−0.5x
PEG Ratio
−1.20−0.260.00
Price/Book
16.2x0.0x2.6x
Price / LTM Sales
54.4x16.4x3.3x
Upside (Analyst Target)
307.4%243.8%41.6%
Fair Value Upside
Unlock−4.6%5.9%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
1.19M / --
EPS Revisions
Last 90 days

OBI Income Statement

FAQ

What Stock Exchange Does Ondine Biomedical Trade On?

Ondine Biomedical is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Ondine Biomedical?

The stock symbol for Ondine Biomedical is "OBI."

What Is the Ondine Biomedical Market Cap?

As of today, Ondine Biomedical market cap is 59.97M.

What Is Ondine Biomedical's Earnings Per Share (TTM)?

The Ondine Biomedical EPS (TTM) is -0.07.

From a Technical Analysis Perspective, Is OBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Ondine Biomedical Stock Split?

Ondine Biomedical has split 0 times.

How Many Employees Does Ondine Biomedical Have?

Ondine Biomedical has 18 employees.

What is the current trading status of Ondine Biomedical (OBI)?

As of 13 Aug 2025, Ondine Biomedical (OBI) is trading at a price of 14.50, with a previous close of 13.50. The stock has fluctuated within a day range of 14.50 to 14.85, while its 52-week range spans from 5.50 to 15.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.